Summary of ASH 2018

Jack Aiello |

December 4, 2018 Before presenting my ASH summary, I’ll mention a late-breaking abstract presentation that I was unable to attend early this morning focused on a phase III trial using Darzalex (daratumumab) in front-line therapy plus Rev-dex versus Rev-dex only for transplant-ineligible patients. The abstract # LBA-2 showed that the addition of Dara decreased the […]

Back To ‘Normal’ Life

Linda Huguelet |

Well, it’s 5:00 a.m. PT, although I keep telling myself that’s 8:00 a.m. ET, so it doesn’t seem so early. I’m at the San Diego airport waiting for my flight back home from the 2018 American Society of Hematology (ASH) annual meeting and exposition. It has been four, long, intense days of being totally immersed […]

Snoopy Philosophy

John DeFlice |

CHARLIE BROWN:  Someday we will die, Snoopy. SNOOPY:  True, but all the other days, we will not. Snoopy’s philosophy resonates at ASH 2018 because of all the exciting information on immunotherapy.  There are new approaches to the use of daratumumab with other agents in quadruple combinations that result in high rate of response in newly […]

Day 2: A Busy Day at ASH

Jack Aiello |

Day 2: A busy day at ASH December 2, 2018 Today I attended oral presentations from 8 a.m. to 6 p.m. with a few short breaks to check out posters and exhibits as well as meet with Pharma companies. Let me discuss several findings from several oral presentations (#abstract). Maintenance Therapy with Ninlaro (Ixazomib)….Tourmaline 3 […]

We’ve Come a Long Way and There’s No End in Sight

Linda Huguelet |

Each year at the American Society of Hematology (ASH) annual meeting, I’ve been overwhelmed by the amount of research underway to bring new treatments and hopefully a cure to multiple myeloma patients. Thankfully, this year is no different; however, last night I was reminded just how far we’ve come in a relatively short period of […]

“The Times, They Are A-Changing”

Michael Tuohy |

As you may know, I was diagnosed in 2000 when I was 36 years old. Who knew back then how much research would increase to give us all real hope for a cure for myeloma. The IMF has even launched clinical trials named “CURE” Trials! I attended my first ASH, I believe in 2005.  I […]

@MyelomaTeacher … #PatientsIncluded at #ASH18

Cynthia Chmielewski |

I am looking forward to shedding my puffy winter jacket and traveling to sunny San Diego to attend the 60th Annual Meeting of the American Society of Hematology (#ASH18) with the International Myeloma Foundation (IMF). This will be the seventh time I have attended ASH, but going to this meeting never gets old. I anxiously […]

Hope Structures Your Life

John DeFlice |

As Mary Lamia, a clinical psychologist, says “Hope structures your life in anticipation of the future and influences how you feel in the present. There is no question that today there is great cause for hope in the treatment of Multiple Myeloma (MM).  It is with this hope I am excited to be attending ASH […]